Skylight Psychedelics

Psychedelics in the press

Morgan Stanley Positive in First Psychedelics Research Report

The psychedelics industry received a boost in confidence this week by way of a new market report from banking giant Morgan Stanley. By Bryan Mc Govern – 8/3/2022 Morgan Stanley (NYSE:MS) has shared its first official commentary on the psychedelics industry. The concept of investing in psychedelic medicine received a legitimate vote of confidence of […]

Morgan Stanley Positive in First Psychedelics Research Report Read More »

Americans Take Ketamine at Home for Depression With Little Oversight

Psychiatrists express concern about the safety of taking the mind-altering anesthetic at home. By Brianna Abbott and Daniela Hernandez – 10/30/2022 Startups are prescribing ketamine online to treat serious mental-health conditions, raising concern among psychiatrists about the safety of taking the mind-altering anesthetic without medical supervision, sometimes at high doses that raise risks of side

Americans Take Ketamine at Home for Depression With Little Oversight Read More »

Ketamine: A Promising Novel Therapy for Anxiety and PTSD

Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD).1,2 Several studies have also found it to be effective for treating suicidal ideation.3,4 “Ketamine can play an important role in the treatment

Ketamine: A Promising Novel Therapy for Anxiety and PTSD Read More »

San Francisco decriminalizes psychedelics

By Max Savage Levenson, 9/7/2022 Last night, Sept. 6, the San Francisco Board of Supervisors gave unanimous approval to a resolution that effectively decriminalizes entheogens and their compounds for adult use. The resolution defines entheogens as the “full spectrum of plants, fungi, and natural materials that can inspire personal and spiritual well-being.” That list includes

San Francisco decriminalizes psychedelics Read More »

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows

Psilocybin, the ingredient in magic mushrooms, along with talk therapy, showed significant benefit in the largest clinical trial of its kind. By Kaitlin Sullivan, Akshay Syal, M.D., Kori Lynch and Harry Smith Two doses of psilocybin pills, along with psychotherapy, helped people with alcohol use disorder reduce drinking for at least eight months after their

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows Read More »

New Study Estimates Over 5.5 Million U.S. Adults Use Hallucinogens

PAST 12-MONTH LSD USE RATE INCREASED FROM 0.9 PERCENT IN 2002 TO 4 PERCENT IN 2019 Hallucinogen use has increased since 2015, overall and particularly among adults 26 and older, while use decreased in adolescents aged 12–17 years according to a new study by Columbia University Mailman School of Public Health and Columbia University Irving

New Study Estimates Over 5.5 Million U.S. Adults Use Hallucinogens Read More »

Shopping cart0
There are no products in the cart!
Continue shopping
0